Hypertension Diagnostics (HDII) Income Statement
Hypertension Diagnostics Income Statement
Last quarter (Q2 2021), Hypertension Diagnostics's total revenue was $0.00. In Q2, Hypertension Diagnostics's net income was $-5.50K. See Hypertension Diagnostics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 21 | Dec 20 | Dec 19 | Dec 18 | Dec 17 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 3.79M | $ 3.68M | |
| $ 0.00 | $ 0.00 | $ 0.00 | $ 954.47K | $ 752.39K | |
| $ 121.89K | $ 11.00K | $ 419.99K | $ 1.11M | $ 1.16M | |
| Depreciation and Amortization | $ 228.49K | $ 236.56K | $ 206.30K | $ 36.00K | $ 31.30K |
| $ 135.24K | $ 225.56K | $ 3.50M | $ 72.29K | $ -179.00K | |
| $ -121.89K | $ -11.00K | $ -420.00K | $ -161.00K | $ -403.00K | |
| $ 28.65K | $ 0.00 | $ 3.71M | $ 35.58K | $ 34.88K | |
| $ -93.25K | $ -11.00K | $ 3.29M | $ -125.00K | $ -369.00K | |
| $ -93.25K | $ -11.00K | $ 3.29M | $ -125.00K | $ -369.00K | |
| Per Share Metrics | |||||
| Basic EPS | $ 0.00 | $ 0.00 | $ 0.02 | $ -0.00 | $ -0.00 |
| Diluted EPS | $ 0.00 | $ 0.00 | $ 0.02 | $ -0.00 | $ -0.00 |
| Weighted Average Shares Outstanding | 213.09M | 149.18M | 136.81M | 136.81M | 93.35M |
| Weighted Average Shares Outstanding (Diluted) | 213.09M | 149.18M | 136.81M | 136.81M | 93.35M |
Currency in USD
